Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Recombinant Teriparatide for Injection

Approval Number

国药准字S20190037

Company信立泰（苏州）药业有限公司

Registration Date

September 29, 2019

Drug Information

Generic Name

注射用重组特立帕肽

Trade Name

欣复泰

Brand Name

欣复泰

Dosage Form

注射剂

Strength

200IU/20μg/瓶

Drug Type

生物制品

Registration Date

September 29, 2019

Company Information

Applicant Company

Company Name信立泰（苏州）药业有限公司

Company Address

太仓市沙溪镇梦溪路1号

Manufacturing Company

Company Name信立泰（苏州）药业有限公司

Company Address

太仓市沙溪镇梦溪路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy